SEARCH

SEARCH BY CITATION

References

  • 1
    European Academy of Allergology and Clinical Immunology. European position paper on rhinosinusitis and nasal polyps. Rhinol 2005;18(Suppl.):187.
  • 2
    Berger G, Kattan A, Bernheim J, Ophir D. Polypoid mucosa with eosinophilia and glandular hyperplasia in chronic sinusitis: a histopathological and immunohistochemical study. Laryngoscope 2002;112:738745.
  • 3
    Bachert C, Wagenmann M, Hauser U, Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997;99:837842.
  • 4
    Rudack C, Stoll W, Bachert C. Cytokines in nasal polyposis, acute and chronic sinusitis. Am J Rhinol 1998;12:383388.
  • 5
    Min YG, Lee CH, Rhee CS, Hong SK, Kwon SH. Increased expression of IL-4, IL-5, IFN-gamma, IL-6, IL-8, and TGF-beta mRNAs in maxillary mucosa of patients with chronic sinusitis. Am J Rhinol 1999;13:339343.
  • 6
    Bolard F, Gosset P, Lamblin C, Bergoin C, Tonnel AB, Wallaert B. Cell and cytokine profiles in nasal secretions from patients with nasal polyposis: effects of topical steroids and surgical treatment. Allergy 2001;56:333338.
  • 7
    Bachert C, Gevaert P, Holtappels G, Van Cauwenberge P. Mediators in nasal polyposis. Curr Allergy Asthma Rep 2002;2:481487.
  • 8
    Gevaert P, Bachert C, Holtappels G, Novo CP, Van der Heyden J, Fransen L et al. Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis. Allergy 2003;58:371379.
  • 9
    Chen YS, Arab SF, Westhofen M, Lorenzen J. Expression of interleukin-5, interleukin-8, and interleukin-10 mRNA in the osteomeatal complex in nasal polyposis. Am J Rhinol 2005;19:117123.
  • 10
    Vento SI, Wolff CH, Salven PJ, Hytonen ML, Ertama LO, Malmberg CH. Vascular permeability factor/vascular endothelial growth factor in nasal polyps. Acta Otolaryngol 2000;543(Suppl.):170174.
  • 11
    Harlin SL, Ansel DG, Lane SR, Myers J, Kephart GM, Gleich GJ. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol 1988;81:867875.
  • 12
    Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 2002;3:409421.
  • 13
    Wert SE, Yoshida M, LeVine AM, Ikegami M, Jones T, Ross GF et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci U S A 2000;97:59725977.
  • 14
    Fujisawa T, Kato Y, Terada A, Iguchi K, Kamiya H. Matrix metalloproteinase-9 in peripheral blood eosinophils. Int Arch Allergy Immunol 1999;120(Suppl. 1):6569.
  • 15
    Lee YM, Kim SS, Kim HA, Suh YJ, Lee SK, Nahm DH et al. Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1. J Korean Med Sci 2003;18:97102.
  • 16
    Bhandari A, Takeuchi K, Suzuki S, Harada T, Hayashi S, Imanaka-Yoshida K et al. Increased expression of matrix metalloproteinase-2 in nasal polyps. Acta Otolaryngol 2004;124:11651170.
  • 17
    Watelet JB, Bachert C, Claeys C, Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004;59:5460.
  • 18
    Lechapt-Zalcman E, Coste A, D'Ortho MP, Frisdal E, Harf A, Lafuma C et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 2001;193:233241.
  • 19
    Watelet JB, Demetter P, Claeys C, Van Cauwenberge P, Cuvelier C, Bachert C. Neutrophil-derived metalloproteinase-9 predicts healing quality after sinus surgery. Laryngoscope 2005;115:5661.
  • 20
    Shaida A, Kenyon G, Devalia J, Davies RJ, MacDonald TT, Pender SL. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. J Allergy Clin Immunol 2001;108:791796.
  • 21
    Coraux C, Martinella-Catusse C, Nawrocki-Raby B, Hajj R, Burlet H, Escotte S et al.. Differential expression of matrix metalloproteinases and interleukin-8 during regeneration of human airway epithelium in vivo. J Pathol 2005;206:160169.
  • 22
    Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003;170:33693376.
  • 23
    Contasta I, Berghella AM, Pellegrini P, Del Beato T, Casciani CA, Adorno D. Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network. Cancer Biother Radiopharm 1999;14:465475.
  • 24
    Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999;58:691697.
  • 25
    Ivanoff A, Ivanoff J, Hultenby K, Sundqvist KG. Infiltrative capacity of T leukemia cell lines: a distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1). Clin Exp Metastasis 1999;17:695711.
  • 26
    Buisson AC, Zahm JM, Polette M, Pierrot D, Bellon G, Puchelle E et al. Gelatinase B is involved in the in vitro wound repair of human respiratory epithelium. J Cell Physiol 1996;166:413426.
  • 27
    Suzuki H, Takahashi Y, Wataya H, Ikeda K Nakabayashi S, Shimomura A et al. Mechanism of neutrophil recruitment induced by IL-8 in chronic sinusitis. J Allergy Clin Immunol 1996;98:659670.
  • 28
    Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997;17:519528.
  • 29
    Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992;298:2932.
  • 30
    Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol 1999;30:795802.
  • 31
    Mautino G, Henriquet C, Jaffuel D, Bousquet J, Capony F. Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects. Am J Respir Crit Care Med 1999;160:324330.
  • 32
    Sato T, Ito A, Mori Y. Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. Biochem Biophys Res Commun 1990;170:824829.
  • 33
    Ghaffar O, Lavigne F, Kamil A, Renzi P, Hamid Q. Interleukin-6 expression in chronic sinusitis: colocalization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells. Otolaryngol Head Neck Surg 1998;118:504511.
  • 34
    Bradley DT, Kountakis SE. Role of interleukins and transforming growth factor-beta in chronic rhinosinusitis and nasal polyposis. Laryngoscope 2005;115:684686.
  • 35
    Chakrabarti S, Patel KD. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J Leukoc Biol 2005;78:279288.
  • 36
    Van Toorenenbergen AW, Gerth Wijk van R, Vermeulen AM. Allergen-induced matrix metalloproteinase-9 in nasal lavage fluid. Allergy 1999;54:293294.